455
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Tegillarca granosa extract Haishengsu inhibits the expression of p-glycoprotein and induces apoptosis in drug-resistant K562/ADM cells

, , , , &
Pages 529-533 | Received 12 Sep 2008, Accepted 12 Feb 2009, Published online: 17 Mar 2010

Figures & data

Table 1. Haishengsu (HSS) induced apoptosis in the K562/ADM cells.

Figure 1. Effect of Haishengsu (HSS) on the apoptosis of K562/ADM cells. There was an increase in apoptosis from lower to the higher HSS groups. (A) control group, (B) Haishengsu (10 μg/mL); (C) Haishengsu (20 μg/mL); (D) Haishengsu (40 μg/mL).

Figure 1.  Effect of Haishengsu (HSS) on the apoptosis of K562/ADM cells. There was an increase in apoptosis from lower to the higher HSS groups. (A) control group, (B) Haishengsu (10 μg/mL); (C) Haishengsu (20 μg/mL); (D) Haishengsu (40 μg/mL).

Table 2. Optical density value of control and study groups.

Figure 2. The expression of caspase-3 and Bcl-2 in the HSS and control (H0) groups. H1, H2 and H3 denote the concentration of HSS at 10, 20 and 40 μg/mL, respectively. There was a thickening in the 29 KD caspase-3 bands from H0 to H3 groups. There was a thinning in the 26 KD Bcl-2 bands.

Figure 2.  The expression of caspase-3 and Bcl-2 in the HSS and control (H0) groups. H1, H2 and H3 denote the concentration of HSS at 10, 20 and 40 μg/mL, respectively. There was a thickening in the 29 KD caspase-3 bands from H0 to H3 groups. There was a thinning in the 26 KD Bcl-2 bands.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.